He has also performed cancer research at the Otto-von-Guericke Universität in Magdeburg, Germany, and gastrointestinal oncology training at the University of Amsterdam’s Academish Medisch Centrum. He received his medical degree from the University of Kansas School of Medicine, where he was elected to the Alpha Omega Alpha Medical Honor Society. Bajaj was raised in Overland Park, KS, and graduated with honors from the University of Kansas, receiving dual degrees in biology and genetics. He presently serves as an Associate Professor of Radiation Oncology for the University of Maryland School of Medicine, Virginia Commonwealth University School of Medicine and the Uniformed Services University of the Health Sciences.ĭr.
Bajaj oversees one of the nation’s busiest practices for the treatment of Dupuytren’s and Ledderhose diseases with radiotherapy and is actively involved in research, physician training and patient advocacy for these conditions. His additional area of interest includes radiation therapy for benign disease, with a specific focus on Dupuytren’s and Ledderhose diseases.ĭr.
His clinical focus and academic interests center on providing high level, multidisciplinary treatment to patients with head and neck malignancies, educating the next generation of medical specialists, exploring novel mechanisms of radiation-associated toxicity management, and working with emerging technologies in radiation oncology.
Prior to joining the radiation oncology practice at Inova Fairfax Hospital, he was an instructor in radiation oncology, medical oncology, and otolaryngology head and neck surgery at Johns Hopkins Hospital. Gopal Bajaj is the President of Radiation Oncology Associates, PC, and the emeritus Chairman and Medical Director of the Department for Advanced Radiation Oncology and Proton Therapy for Inova Schar Cancer Institute, having served in this role from 2014 to 2020.
0 kommentar(er)
